Champions Oncology Inc Stock
Your prediction
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | 1.980% | 1.980% | -10.435% | 8.193% | 8.193% | -17.600% | -44.022% |
| Ardelyx Inc. | 0.640% | 2.840% | 4.881% | 6.187% | 6.465% | 184.469% | -6.409% |
| Krystal Biotech | -2.300% | 3.678% | 18.962% | 33.718% | 37.057% | 193.803% | - |
| Evolus Inc | 1.750% | -1.724% | -7.317% | -46.729% | -45.714% | -13.636% | 73.622% |
News
3 Dividend Champion Stocks I'm Watching in 2025
If you are looking for high-yield stocks in a stock market that is hovering near all-time highs, a good place to start your search is with reliable dividend payers.
Dividend Champions fit the bill
Keep an Eye on These 3 Dividend Champion Stocks in 2025
A streak lasting decades is noteworthy. Whether it's a silver wedding anniversary, a quarter century of work, or The Simpsons' 37-year run, these show stability and success.
You can find examples in
7 Best Dividend Champions to Buy Now
Dividend Champions are long-term winners. These companies have grown their dividends for at least 25 straight years. They don't have to be members of the S&P 500 (SNPINDEX: ^GSPC), which broadens